AeroLeads people directory · profile

Peter Honig Email & Phone Number

Managing Director at Blackstone
Location: Collegeville, Pennsylvania, United States 27 work roles 4 schools
1 work email found @pfizer.com 1 phone found area 212 LinkedIn matched
✓ Verified Jun 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 1 phone

Work email p****@pfizer.com
Direct phone (212) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Blackstone
Role
Managing Director
Location
Collegeville, Pennsylvania, United States
Company size
7458 employees

Who is Peter Honig? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Peter Honig is listed as Managing Director at Blackstone, a company with 7458 employees, based in Collegeville, Pennsylvania, United States. AeroLeads shows a work email signal at pfizer.com, phone signal with area code 212, and a matched LinkedIn profile for Peter Honig.

Peter Honig previously worked as Executive Advisor to Blackstone Life Sciences at Blackstone and Member Board Of Directors at Drug Information Association (Dia). Peter Honig holds Fellowship, Clinical Pharmacology from Uniformed Services University.

Company email context

Email format at Blackstone

This section adds company-level context without repeating Peter Honig's masked contact details.

{first}.{last}@pfizer.com
86% confidence

AeroLeads found 1 current-domain work email signal for Peter Honig. Compare company email patterns before reaching out.

View email format View company profile Management contacts
Profile bio

About Peter Honig

Dr. Peter Honig is an experienced leader in the strategic and tactical aspects of drug and vaccine development with expertise in clinical pharmacology, clinical program and clinical trial design, compliance, medical product safety, and medical product regulation. Before joining Pfizer, he held leadership positions at AstraZeneca and Merck. Prior to joining Merck, Dr. Honig founded and was the first Director of the Office of Drug Safety in the Food and Drug Administration's (FDA) Center for Drug Evaluation and Research He is a past President of American Society of Clinical Pharmacology and Therapeutics (ASCPT)and is the PhRMA representative to the International Conference on Harmonization (ICH) Steering Committee. He is also currently a Board Director at Celladon and Orexigen Therapeutics and an industry representative to the Executive Committee of the Biomarkers Consortium. He received his baccalaureate, medical and public health degrees from Columbia University in New York is board-certified in internal medicine and clinical pharmacology and has authored numerous peer reviewed publications and book chapters and is a current Associate Editor of Clinical Pharmacology and Therapeutics.

Listed skills include Clinical Development, Regulatory Affairs, Clinical Trials, Pharmaceutical Industry, and 46 others.

Current workplace

Peter Honig's current company

Company context helps verify the profile and gives searchers a useful next step.

Blackstone
Blackstone
Managing Director
Collegeville, PA, US
Website
blackstone.com
Employees
7458
AeroLeads page
Company profile
View company profile Email format
27 roles · 44 years

Peter Honig work experience

A career timeline built from the work history available for this profile.

Managing Director

Blackstone

Collegeville, PA, US

Managing Director

Current
Blackstone

New York, NY, US

Jul 2023 - Present

Executive Advisor To Blackstone Life Sciences

Blackstone

New York, NY, US

Feb 2022 - Jul 2023

Board Member

Current
Centre Of Regulatory Excellence (Core)

The Centre of Regulatory Excellence (CoRE) was established with support from Singapore’s Economic Development Board, Health Sciences Authority and Ministry of Health as the first Asian Centre dedicated to addressing the capacity development and policy innovation needs of national health product and health systems regulators, the biomedical industry.

Aug 2020 - Present

Advisory Board Member

Current
The Accelerating Therapeutics For Opportunities In Medicine (Atom) Consortium

The Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium is a public-private partnership with the mission of transforming drug discovery by accelerating the development of more effective therapies for patients

Jan 2020 - Present

Independent Board Member

Aeriumtx

Aerium is dedicated to the discovery & development of antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic & pandemic threats. https://www.aeriumtx.com

Mar 2022 - May 2024

Member Board Of Directors

Alopexx Enterprises, Llc

Concord, Massachusetts, US

Alopexx is clinical stage biotechnology company focusing on developing novel, broad-spectrum immune-mediated therapeutics for the prevention and treatment of a wide range of bacterial, fungal and parasitic microbial infections.

Oct 2021 - Sep 2023

Board Member

Sesen Bio

Sesen Bio, Inc. is a late-stage clinical company advancing targeted fusion protein therapeutics for the treatment of patients with cancer. https://www.sesenbio.com

Jul 2021 - Mar 2023

Scientific Advisory Board

Travecta Therapeutics

Travecta is an emerging biotech company utilizing its novel Blood-Brain Barrier Transport Platform to develop a proprietary pipeline of molecules that treat disorders of the central nervous system. The Travecta Platform leverages our proprietary knowledge of the MFSD2a Transport for the targeted delivery of therapeutic agents to the brain.

Oct 2021 - Sep 2022

Associate Editor

Clinical Pharmacology And Therapeutics
Jan 2009 - Nov 2021

Svp

Pfizer

New York, New York, US

May 2014 - Jul 2021

Management Committee Member

International Committee On Harmonization

The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is unique in bringing together the regulatory authorities and pharmaceutical industry to discuss scientific and technical aspects of pharmaceuticals and develop ICH guidelines. Since its inception in 1990, ICH has gradually evolved, to respond to.

Feb 2002 - Jul 2021

Executive Committee

Biomarkers Consortium

The Biomarkers Consortium is a public-private biomedical research partnership managed by the Foundation for the National Institutes of Health (FNIH) that endeavors to discover, develop and seek regulatory approval for biological markers (biomarkers) to support new drug development, preventative medicine and medical diagnostics.

Mar 2013 - May 2021

Advisory Board Member

Excellentia Global Partners
Jan 2010 - Jan 2020

Board Director

Celladon Corporation
Jan 2014 - Mar 2016

Head, Global Regulatory Affairs

Astrazeneca

Cambridge, Cambridgeshire, GB

Jul 2010 - May 2014

Vp And Head, Global Regulatory Affairs

Astrazeneca

Cambridge, Cambridgeshire, GB

Jul 2010 - May 2014

Member, Committee On Scientific Standards For Studies On Modified Risk Tobacco Products

Institue Of Medicine
Jun 2010 - Sep 2011

Clinical Advisory Board

Generation Health
Jan 2010 - Sep 2010

Senior Advisor

B&D Consulting

Washington, DC, US

Jan 2010 - Jun 2010

Pharmaceutical Consultant

Peter Honig Regulatory And Medical Advisors, Llc
Jan 2010 - May 2010

Merck Research Laboratories

Merck

Rahway, New Jersey, US

Worldwide Regulatory Affairs and Product Safety

Mar 2002 - Dec 2009

Housestaff

Northwestern University
1982 - 1985 ~3 yrs
Team & coworkers

Colleagues at Blackstone

Other employees you can reach at blackstone.com. View company contacts for 7458 employees →

KP Kaitlyn Paolo Hein Kaitlyn Paolo Hein Colleague at BlackstoneNew York City Metropolitan Area, United States View → AS Abbie Sandford Abbie Sandford Colleague at BlackstoneLondon, England, United Kingdom, United Kingdom View → PP Prasanna Pathipati Prasanna Pathipati Colleague at BlackstoneEdison, New Jersey, United States, United States View → GZ George Zepos George Zepos Colleague at BlackstoneLondon, England, United Kingdom, United Kingdom View → AA Alper Ayyildiz Alper Ayyildiz Colleague at BlackstoneIstanbul, Istanbul, Türkiye, Turkey View → NF Noah Fritz Noah Fritz Colleague at BlackstoneNew York, New York, United States, United States View → VL Verena Letzerich Verena Letzerich Colleague at BlackstoneLondon, England, United Kingdom, United Kingdom View → MM Mali Monges, M.A. Mali Monges, M.A. Colleague at BlackstoneNew York City Metropolitan Area, United States View → RG Raghav Gupta Raghav Gupta Colleague at BlackstoneGurugram, Haryana, India, India View → YS Yasmina S. Yasmina S. Colleague at BlackstoneUnited Kingdom, United Kingdom View →
4 education records

Peter Honig education

Fellowship, Clinical Pharmacology

Uniformed Services University

Mph

Columbia University

Doctor Of Medicine (Md)

Columbia University Vagelos College Of Physicians And Surgeons

Ba, History

Columbia University
FAQ

Frequently asked questions about Peter Honig

Quick answers generated from the profile data available on this page.

What company does Peter Honig work for?

Peter Honig works for Blackstone.

What is Peter Honig's role at Blackstone?

Peter Honig is listed as Managing Director at Blackstone.

What is Peter Honig's email address?

AeroLeads has found 1 work email signal at @pfizer.com for Peter Honig at Blackstone.

What is Peter Honig's phone number?

AeroLeads has found 1 phone signal(s) with area code 212 for Peter Honig at Blackstone.

Where is Peter Honig based?

Peter Honig is based in Collegeville, Pennsylvania, United States while working with Blackstone.

What companies has Peter Honig worked for?

Peter Honig has worked for Blackstone, Drug Information Association (Dia), Centre Of Regulatory Excellence (Core), The Accelerating Therapeutics For Opportunities In Medicine (Atom) Consortium, and Aeriumtx.

Who are Peter Honig's colleagues at Blackstone?

Peter Honig's colleagues at Blackstone include Kaitlyn Paolo Hein, Abbie Sandford, Prasanna Pathipati, George Zepos, and Alper Ayyildiz.

How can I contact Peter Honig?

You can use AeroLeads to view verified contact signals for Peter Honig at Blackstone, including work email, phone, and LinkedIn data when available.

What schools did Peter Honig attend?

Peter Honig holds Fellowship, Clinical Pharmacology from Uniformed Services University.

What skills is Peter Honig known for?

Peter Honig is listed with skills including Clinical Development, Regulatory Affairs, Clinical Trials, Pharmaceutical Industry, Fda, Pharmacovigilance, Drug Development, and Clinical Research.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.